N1,N1-Bis(1H-1,2,3-benzotriazol-1-ylmethyl)-N4,N4-dimethylbenzene-1,4-diamine, 250mg

(R)-(1-Methylpyrrolidin-3-yl)methanol, 95.0%, 10g

(+/-)-Thalidomide, 98%, 25g

(2R,3R,4S,5R)-2-(6-Amino-8-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97%, 250mg

Cell culture flasks, 75 cm², 250 ml, 15-38 ml 120 pieces

(4R)-4-(AMINOMETHYL)-1-METHYLPYRROLIDIN-2-ONE, 95%, 1g

Diethyl Methyloxalacetate>96.0%(GC)25g

2-(1H-PYRAZOL-1-YL)-5-(TRIFLUOROMETHYL)PYRIMIDINE, 95.0%, 100mg

Benzyl Azide, Pract., 94.0%, 10g

4-(5-(1-methyl-2-oxoindolin-3-ylidene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid, 95.0%, 250mg

4-Amylcyclohexanol (cis- and trans- mixture)>98.0%(GC)25g

(S)-(6-Fluoro-1,2,3,4-tetrahydroisoquinolin-3-yl)methanol, 97%, 100mg

3-Cyano-2-phenylpropanoic acid, 95%, 1g